Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass that specifically targets transforming growth factor-beta 2 (TGF-??2). This antibody is utilized in research as an anti-scarring agent, particularly in studies related to glaucoma. Its mechanism of action involves neutralizing the biological activity of TGF-??2, a cytokine implicated in the pathogenesis of fibrosis and scarring.
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass that specifically targets transforming growth factor-beta 2 (TGF-??2). This antibody is utilized in research as an anti-scarring agent, particularly in studies related to glaucoma. Its mechanism of action involves neutralizing the biological activity of TGF-??2, a cytokine implicated in the pathogenesis of fibrosis and scarring.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
